Kintara Therapeutics Price on June 14, 2024
| KTRADelisted Stock | USD 6.30 0.14 2.17% |
If you're considering investing in Kintara Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kintara Therapeutics stands at 6.30, as last reported on the 30th of December, with the highest price reaching 7.93 and the lowest price hitting 5.61 during the day. Kintara Therapeutics appears to be risky, given 3 months investment horizon. Kintara Therapeutics has Sharpe Ratio of 0.0269, which conveys that the firm had a 0.0269% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Kintara Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Kintara Therapeutics' Standard Deviation of 6.76, mean deviation of 5.18, and Risk Adjusted Performance of (0.04) to check out if our risk estimates are consistent with your expectations.
Kintara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Kintara |
Sharpe Ratio = 0.0269
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KTRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.24 actual daily | 73 73% of assets are less volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Kintara Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kintara Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Lumos Pharma Headline on 14th of June 2024
Disposition of 25500 shares by Pitukcheewanont Pisit Duke of... by Pitukcheewanont Pisit Duke
Filed transaction by Lumos Pharma Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Kintara Therapeutics Valuation on June 14, 2024
It is possible to determine the worth of Kintara Therapeutics on a given historical date. On June 14, 2024 Kintara was worth 6.83 at the beginning of the trading date compared to the closed value of 6.42. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kintara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Kintara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kintara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kintara Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.14 | 7.14 | 6.33 | 6.55 | 2,660,108 | |
06/14/2024 | 6.83 | 6.83 | 6.31 | 6.42 | 1,835,960 |
| 6.66 | 6.83 | 5.96 | 6.27 | 4,887,735 |
| Backtest Kintara Therapeutics | | | Kintara Therapeutics History | | | Kintara Therapeutics Valuation | Previous | Next |
Kintara Therapeutics Trading Date Momentum on June 14, 2024
| On June 17 2024 Kintara Therapeutics was traded for 6.27 at the closing time. The top price for the day was 6.83 and the lowest listed price was 5.96 . The trading volume for the day was 4.9 M. The trading history from June 17, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.34% . The trading delta at closing time against the current closing price is 39.10% . |
Kintara Therapeutics Fundamentals Correlations and Trends
By evaluating Kintara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kintara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kintara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kintara Therapeutics Stock history
Kintara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kintara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kintara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kintara Therapeutics stock prices may prove useful in developing a viable investing in Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California. Kintara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Kintara Therapeutics Stock Technical Analysis
Kintara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Kintara Therapeutics Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Kintara Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kintara Therapeutics December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Kintara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kintara Therapeutics shares will generate the highest return on investment. By undertsting and applying Kintara Therapeutics stock market strength indicators, traders can identify Kintara Therapeutics entry and exit signals to maximize returns
Kintara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kintara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Kintara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kintara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (1.95) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Kintara Stock
If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |